About the BZKF
Cancer research in Bavaria
The Bavarian Center for Cancer Research (BZKF) was founded in 2019 with the aim of providing all citizens in Bavaria with access to the best possible, latest and innovative cancer therapies - regardless of where they live.
Prof. Dr. Andreas Mackensen
Director of the Bavarian Center for Cancer Research (BZKF)
From science into practice
The BZKF is an association of the six Bavarian university hospitals and universities in Augsburg, Erlangen, Munich, Regensburg and Würzburg.
Cancer research is promoted and knowledge is pooled in the university hospitals and the research and care centers supported by the universities, the Comprehensive Cancer Centers (CCCs). In line with the motto "Strengthening excellence - sharing knowledge", scientists at the BZKF sites conduct interdisciplinary research into the development and treatment of cancer in close cooperation. Clinical studies are conducted and shared across the sites.
The aim is to quickly transfer results into clinical practice and significantly improve the care of cancer patients in Bavaria.
"At the BZKF, the transfer of results from basic research into practice has absolute priority. One focus is on the joint implementation of clinical studies."
Prof. Dr. Andreas Mackensen, Director of the Bavarian Center for Cancer Research (BZKF)
Markus Blume, Bavarian Minister of State for Science and the Arts
(Image source: StMWK/Böttcher)
Best possible care throughout Bavaria
The distribution of the locations ensures that cancer patients throughout Bavaria have access to cutting-edge oncological medicine and the best possible cancer treatment based on the latest scientific findings close to where they live. The Bavarian Center for Cancer Research (BZKF) provides the Bavarian population with direct access to information on the latest research findings, diagnosis and treatment options and ensures that innovative methods are used across the board in the diagnosis and treatment of cancer.
"Despite constant progress in medical research, the diagnosis of cancer has lost little of its horror to this day. That is why we are doing everything we can to offer those affected and their families the best possible help with medical structures at the highest level. The Bavarian Center for Cancer Research (BZKF) combines outstanding oncological research with high-performance cutting-edge medicine."
Markus Blume, Bavarian State Minister for Science and the Arts
Information and advice
The BZKF has set up a free telephone service for questions about cancer and possible points of contact. The BürgerTelefonKrebsoffers patients and their relatives advice and help. The staff are competent and experienced and respond individually to the needs of those seeking advice.
Monday to Friday, 08:30 to 12:30
Free telephone number: 0800 - 85 100 80
E-Mail: buergertelefon@bzkf.de
The goals of the BZKF at a glance:
- Significantly improve care for cancer patients in Bavaria
- Enabling access to the best possible, latest and innovative therapies
- Advancing preclinical cancer research
- Transferring scientific findings quickly into clinical application
- Carry out clinical studies across all six sites
- Best possible information and advice for citizens
- Offer a free cancer information service with the BürgerTelefonKrebs
6 Board representatives of the university hospitals
6 Board representatives of the universities
- Dr. Albrecht Bender, University Hospital Erlangen
- Prof. Dr. Stephanie Combs, Technical University of Munich
- Prof. Dr. Sabine Doering-Manteuffel, University of Augsburg
- Prof. Dr. Tim von Oertzen, University Hospital Würzburg
- Prof. Dr. Matthias Frosch, Julius-Maximilians-Universität Würzburg (Deputy Chairman of the Steering Committee)
- Prof. Dr. Thomas Gudermann, LMU Klinikum München (Chairman of the Steering Committee)
- Prof. Dr. Dirk Hellwig, University Hospital Regensburg
- Prof. Dr. Oliver Kölbl, University Hospital Regensburg
- Prof. Dr. Klaus Markstaller, University Hospital Augsburg
- Prof. Dr. Markus F. Neurath, University Hospital Erlangen
- Dr. Martin Siess, TUM Clinic Munich
- Markus Zendler, LMU Clinic Munich
Experts and patient representatives
- Prof. Dr. Michael Baumann, German Cancer Research Center DKFZ, DE
- Prof. Dr. Florian Greten, Institute for Tumor Biology and Experimental Therapy, DE
- Prof. Dr. Markus Manz, University Hospital Zurich, CH
- Prof. Emma Morris, University College Hospital London, UK
- Prof. Dr. Renata Pasqualini, Rutgers Cancer Institute of New Jersey, USA
- Kurt Wagenlehner (patient representative), DE
6 representatives of the coordination teams
12 appointed deputies of the University Medical Center Bavaria
- Prof. Dr. Ralf C. Bargou, University Hospital Würzburg
- Prof. Dr. Florian Bassermann, TUM Hospital Munich
- Prof. Dr. Louisa von Baumgarten, LMU Klinikum Munich
- Prof. Dr. Matthias W. Beckmann, University Hospital Erlangen
- Prof. Dr. Claus Belka, LMU Clinic Munich
- Prof. Dr. phil. Katharina Diehl, FAU Erlangen-Nuremberg
- PD Dr. Ursula Ehmer, TUM Clinic Munich
- Prof. Dr. Hermann Einsele, University Hospital Würzburg
- Prof. Dr. Dr. Michael Frühwald, University Hospital Augsburg
- Prof. Dr. Anne Herrmann-Johns, University Hospital Regensburg
- Prof. Dr. Frederick Klauschen, University Hospital Munich
- Prof. Dr. Andreas Mackensen, University Hospital Erlangen
- Prof. Dr. Dorothee Mielke, University Hospital Augsburg
- Prof. Dr. Tobias Pukrop, University Hospital Regensburg
- Prof. Dr. Hans J. Schlitt, University Hospital Regensburg
- Prof. Dr. Martin Trepel, University Hospital Augsburg
- Prof. Dr. Wolfgang Weber, Technical University of Munich
- Prof. Dr. Wilko Weichert († 10.07.2023), Technical University of Munich
- Prof. Dr. Andrea Wittig-Sauerwein, University Hospital Würzburg
- Prof. Dr. Michael Schoenberg (patient representative)
- Prof. Dr. Thomas Bein (patient representative)
Coordination teams of the locations/CCCs
UK Augsburg UK Erlangen LMU Klinikum TUM UK Regensburg UK Würzburg
BZKF image film
BZKF image film german on YouTube
BZKF image film english on YouTube
